153 related articles for article (PubMed ID: 18455131)
1. Neurodevelopmental outcome of premature infants after exposure to antenatal indomethacin.
Amin SB; Kamaluddeen M; Sangem M
Am J Obstet Gynecol; 2008 Jul; 199(1):41.e1-8. PubMed ID: 18455131
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure.
Shankaran S; Papile LA; Wright LL; Ehrenkranz RA; Mele L; Lemons JA; Korones SB; Stevenson DK; Donovan EF; Stoll BJ; Fanaroff AA; Oh W; Verter J
Am J Obstet Gynecol; 2002 Jul; 187(1):171-7. PubMed ID: 12114906
[TBL] [Abstract][Full Text] [Related]
3. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.
Carlo WA; McDonald SA; Fanaroff AA; Vohr BR; Stoll BJ; Ehrenkranz RA; Andrews WW; Wallace D; Das A; Bell EF; Walsh MC; Laptook AR; Shankaran S; Poindexter BB; Hale EC; Newman NS; Davis AS; Schibler K; Kennedy KA; Sánchez PJ; Van Meurs KP; Goldberg RN; Watterberg KL; Faix RG; Frantz ID; Higgins RD;
JAMA; 2011 Dec; 306(21):2348-58. PubMed ID: 22147379
[TBL] [Abstract][Full Text] [Related]
4. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin tocolysis and neurodevelopmental outcome.
Soraisham AS; Sauve R; Singhal N
Indian J Pediatr; 2011 Aug; 78(8):946-52. PubMed ID: 21318396
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
[TBL] [Abstract][Full Text] [Related]
7. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
[TBL] [Abstract][Full Text] [Related]
8. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants.
Vermillion ST; Newman RB
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1083-6. PubMed ID: 10561622
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental outcome of infants exposed to indomethacin antenatally.
al-Alaiyan S; Seshia MM; Casiro OG
J Perinat Med; 1996; 24(4):405-11. PubMed ID: 8880639
[TBL] [Abstract][Full Text] [Related]
11. Association of Co-Exposure of Antenatal Steroid and Prophylactic Indomethacin with Spontaneous Intestinal Perforation.
Kandraju H; Kanungo J; Lee KS; Daspal S; Adie MA; Dorling J; Ye XY; Lee SK; Shah PS; ;
J Pediatr; 2021 Aug; 235():34-41.e1. PubMed ID: 33741365
[TBL] [Abstract][Full Text] [Related]
12. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA
J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids.
Chawla S; Bapat R; Pappas A; Bara R; Zidan M; Natarajan G
J Matern Fetal Neonatal Med; 2013 Oct; 26(15):1542-7. PubMed ID: 23565886
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of small for gestational age infants born at <27 weeks' gestation.
De Jesus LC; Pappas A; Shankaran S; Li L; Das A; Bell EF; Stoll BJ; Laptook AR; Walsh MC; Hale EC; Newman NS; Bara R; Higgins RD;
J Pediatr; 2013 Jul; 163(1):55-60.e1-3. PubMed ID: 23415614
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus.
Rheinlaender C; Helfenstein D; Pees C; Walch E; Czernik C; Obladen M; Koehne P
Early Hum Dev; 2010 Feb; 86(2):87-92. PubMed ID: 20153127
[TBL] [Abstract][Full Text] [Related]
16. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.
Amin SB; Sinkin RA; Glantz JC
Am J Obstet Gynecol; 2007 Nov; 197(5):486.e1-10. PubMed ID: 17980183
[TBL] [Abstract][Full Text] [Related]
17. Auditory neural maturation after exposure to multiple courses of antenatal betamethasone in premature infants as evaluated by auditory brainstem response.
Amin SB; Guillet R
Pediatrics; 2007 Mar; 119(3):502-8. PubMed ID: 17332203
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998.
Vohr BR; Wright LL; Poole WK; McDonald SA
Pediatrics; 2005 Sep; 116(3):635-43. PubMed ID: 16143580
[TBL] [Abstract][Full Text] [Related]
19. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
20. Association of Antenatal Corticosteroids With Mortality, Morbidity, and Neurodevelopmental Outcomes in Extremely Preterm Multiple Gestation Infants.
Boghossian NS; McDonald SA; Bell EF; Carlo WA; Brumbaugh JE; Stoll BJ; Laptook AR; Shankaran S; Walsh MC; Das A; Higgins RD;
JAMA Pediatr; 2016 Jun; 170(6):593-601. PubMed ID: 27088897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
